Clusterin (Apo J) regulates vascular smooth muscle cell differentiation in vitro

Journal of Cellular Physiology

Volumn 180, Issue 3, 1999, Pages 355-364

  Moulson, Casey L ^a   Millis, Albert J T ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; NODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN SECRETION; PROTEIN STRUCTURE; REGULATORY MECHANISM; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL DIFFERENTIATION; CLONE CELLS; CLUSTERIN; GLYCOPROTEINS; MOLECULAR CHAPERONES; MUSCLE, SMOOTH, VASCULAR; SWINE;

EID: 0032767455     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199909)180:3<355::AID-JCP6>3.0.CO;2-F     Document Type: Article

References (53)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403-410.
2. Aronow BJ, Lund SD, Brown TL, Harmony JK, Witte DP. 1993. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci USA 90:725-729.
3. Blaschuk O, Burdzy K, Fritz IB. 1983. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem 258:7714-7720.
4. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. 1993. Bone morphogenic protein expression in human atherosclerotic lesions. J Clin Invest 91:1800-1809.
5. Brennan MJ, Millis AJT, Fritz KE. 1982. Fibronectin inhibits morphological changes in cultures of vascular smooth muscle cells. J Cell Physiol 112:284-290.
6. Brennan MJ, Millis AJT, Mann DM, Fritz KE. 1983. Structural alterations in fibronectin correlated with morphological changes in smooth muscle cells. Dev Biol 97:391-397.
7. Burkey BF, DeSilva HV, Harmony JA. 1991. Intracellular processing of apolipoprotein J precursor to the mature heterodimer. J Lipid Res 32:1039-1048.
8. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng P-Y, Sawczuk I. 1989. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 9:3473-3481.
9. Campbell GW, Campbell JH. 1995. Development of the vessel wall: overview. In: Schwartz SM, Mecham RP, editors. The vascular smooth muscle cell: molecular and biological responses to extracellular matrix. San Diego, CA: Academic Press, Inc. p 1-10.
10. Chamley-Campbell JH, Campbell GR, Ross R. 1981. Phenotype dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol 89:379-383.
11. Clowes AW, Schwartz SM. 1985. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 56:139-145.
12. Clowes AW, Reidy MA, Clowes MM. 1983. Kinetics of cellular proliferation after arterial injury, I. Smooth muscle growth in the absence of endothelium. Lab Invest 49:327-333.
13. Collard MW, Griswold MD. 1987. Biosynthesis and molecular cloning of sulfated glycoprotein-2 secreted by rat sertoli cells. Biochemistry 26:3297-3303.
14. Davis RL, Weintraub H, Lassar AB. 1987. Expression of a single transfected CDNA converts fibroblasts to myoblasts. Cell 51:87-100.
15. Diemer VD, Hoyle M, Baglioni C, Millis AJT. 1992. Expression of porcine complement cytolysis inhibitor mRNA in cultured aortic smooth muscle cells. J Biol Chem 267:5257-52646.
16. Dilley RJ, McGeachie JK, Prendergast FJ. 1987. A review of the proliferative behavior, morphology and phenotype of vascular smooth muscle cells. Atherosclerosis 63:99-107.
17. Dreher KL, Cowan K. 1991. Expression of antisense transcripts encoding an extracellular matrix protein by stably transfected smooth muscle cells. Eur J Cell Biol 54:1-9.
18. Faris B, Tan TO, Toselli P, Franzblau C. 1992. Long-term neonatal rat aortic smooth muscle cell cultures: a model for the tunica media of a blood vessel. Matrix 12:185-188.
19. French LE, Chonn A, Ducrest E, Baumann B, Belin D, Wohlwend A, Kiss JZ, Sappino A-P, Tchopp J, Schifferli JA. 1993. Murine clusterin: molecular cloning and mRNA localization of a gene associated with epithelial differentiation process during embryogenesis. J Cell Biol 122:1119-1130.
20. Fritz IB, Burdzy K, 1989. Novel action of carnitine: inhibition of aggregation of despersed cells mediated by clusterin, in vitro. J Cell Physiol 140:118-124.
21. Hartmann K, Rauch J, Urban J, Parczyk K, Diel P, Pilarsky C, Appel D, Haase W, Mann K, Weller A, Koch-Brandt C. 1991. Molecular cloning of gp80, a glycoprotein complex secreted by kidney cells in vitro and in vivo. J Biol Chem 266:9924-9931.
22. Ishikawa Y, Akasaka Y, Ishii T, Komiyama K, Masuda S, Asuwa N, Choi-Miura NH, Tomita M. 1998. Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta. Arterioscler Thromb Vasc Biol 18:665-672.
23. Jenne DE, Tschopp J. 1989. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein-2, a constituent of rat testis fluid. Proc Natl Acad Sci USA 86:7123-7127.
24. Jenne DE, Tschopp J. 1992. Clusterin: the intriguing guises of a widely expressed glycoprotein. TIBS 17:154-159.
25. Kirschenlohr HL, Metcalfe JC, Weissberg PL, Grainger DJ. 1995. Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF beta. Cardiovasc Res 29:848-855.
26. Kirszbaum L, Sharpe JA, Murphy BF, d'Apice AJF, Classon B, Hudson P, Walker ID. 1989. Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: a link between the complement and reproductive systems. EMBO J 8:711-718.
27. Kounnas MZ, Loukinova EB, Stefansson S, Harmony JAK, Brewer BH, Strickland DK, Argraves WS. 1995. Identification of glycoprotein 330 as an endocytotic receptor for apolipoprotein J/clusterin. J Biol Chem 270:13070-13075.
28. Kyprianou N, English HF, Isaacs JT. 1990. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Biol Reprod 33:177-186.
29. Li X, Tsai P, Wieder ED, Kribben A, Van Putten V, Schrier RW, Nemenoff RA. 1994. Vascular smooth muscle cells grown on Matrigel. A model of the contractile phenotype with decreased activation of mitogen-activated protein kinase. J Biol Chem 269:19653-19658.
30. Mackness B, Hunt R, Durrington PN, Mackness MI. 1997. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis. Arterioscler Thromb Vasc Biol 17:1233-1238.
31. May JF, Paule WJ, Rounds DE, Blankenhorn DH, Zemplenyi T. 1975. The induction of atherosclerotic plaque-like mounds in cultures of aortic smooth muscle cells. Virchows Arch B Cell Pathol 18:205-211.
32. Mosse PR, Campbell GR, Wang ZL, Campbell JH. 1985. Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest 53: 556-562.
33. Murphy BF, Kirszbaum L, Walker ID, d'Apice AJF. 1988. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest 81:1858-1864.
34. Pankhurst GJ, Bennett CA, Easterbrook-Smith SB. 1998. Characterization of the heparin-binding properties of human clusterin. Biochemistry 37:4823-4830.
35. Pauletto P, Sartore S, Pessina AC. 1994a. Smooth muscle cell proliferation and differentiation in neointima formation and vascular restenosis. Clin Sci 87:467-479.
36. Pauletto P, Sarzani R, Rappelli A, Chiavegato A, Pessina AC, Sartore S. 1994b. Differentiation and growth of vascular smooth muscle cells in experimental hypertension. Am J Hypertens 7:661-674.
37. Pauley RR, Passaniti A, Crow M, Kinsella JL, Papadopoulous N, Monticone B, Lakatta EG, Martin GR. 1992. Experimental models that mimic the differentiation and dedifferentiation of vascular cells. Circulation 86(Suppl III):III-68-III-73.
38. Pauley RR, Passiniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG, Crow MT. 1994. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 75:41-54.
39. Raines EW, Ross R. 1993. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69(Suppl):S30-S37.
40. Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809.
41. Ross R, Klebanoff SJ. 1971. The smooth muscle cell I. In vivo synthesis of connective tissue proteins. J Cell Biol 50:159-171.
42. Schultz EG, Li D, Omiecinski CJ, Muller E, Kleinman HK, Elswick B, Gruzelian PS. 1988. Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J Cell Physiol 134:309-323.
43. Schwartz SM, O'Brien ER, Deblois D, Giachelli CM. 1995. Relevance of smooth muscle replication and development to vascular disease. In: Schwartz SM, Mecham RP, editors. The vascular smooth muscle cell: molecular and biological responses to extracellular matrix. San Diego, CA: Academic Press, Inc. p 81-140.
44. Schwochau GB, Nath KA, Rosenberg ME. 1998. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int 53:1647-1653.
45. Shackelton LM, Mann DM, Millis AJT. 1995. Identification of a 38kDa heparin binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem 270:13076-13083.
46. Silkensen JR, Skubitz KM, Skubitz APN, Chmlelewski DH, Manivel JC, Dvergsten JA, Rosenberg ME. 1995. Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells. J Clin Invest 96:2646-2653.
47. Thomas-Salgar SA, Millis AJT. 1994. Clusterin expression in differentiating smooth muscle cells. J Biol Chem 269:17879-17885.
48. Thyberg J, Palmberg L, Nilsson J, Ksiazek T, Sjoelund M. 1983. Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. Differentiation 25:156-167.
49. Tung PS, Burdzy K, Wong K, Fritz IB. 1992. Competition between cell-substrate and cell-cell interactions. J Cell Physiol 152:410-421.
50. Vukicevic S, Kleinman HK, Luyten FP, Roberts AB, Roche NS, Reddi AH. 1992. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res 202:1-8.
51. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. 1994. TGFβ1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 93:2106-2113.
52. Witte DP, Aronow BJ, Stauderman ML, Stuart WD, Clay MA, Gruppo RA, Jenkins SH, Harmony JAK. 1993. Platelet aggregation releases megakaryocyte synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am J Pathol 143:763-773.
53. Wong P, Pineault J, Lakins J, Taillefer D, Leger J, Wang C, Tenniswood M. 1993. Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis. J Biol Chem 268:5021-5031.